Neonode Inc. (NEON) stock intrinsic value fair value estimate & owner earnings analysis

Neonode, based in Stockholm, Sweden, licenses sensing technology to equipment makers. It has two lines. zForce is an optical touch and gesture technology. Seiko Epson and HP use it in printers, and Alps Alpine and others use it in cars. In September 2025 Neonode put zForce into "maintenance mode": it will keep supporting existing customers but will not sign new ones. MultiSensing is a camera-based technology for monitoring drivers and vehicle cabins, and it is where the company is now putting its money. In 2025 Neonode had $2.06 million of revenue from continuing operations against $10.2 million of operating expenses. Three customers made up 73% of revenue: Seiko Epson (34%), Alps Alpine (19%) and HP (19%). Car shipments carrying Neonode technology fell from about 0.5 million units in 2024 to 0.3 million in 2025. Earnings record. We measure cash generation as operating cash flow, less working-capital swings, stock compensation and the capital spending needed to keep the business running. On that basis Neonode has not had a single positive year in the ten years from 2016 to 2025. The best year was 2018 at -$0.54 per share; the worst were 2016 at -$1.35 and 2025 at -$0.66. Reported 2025 net income of $8.5 million came from a one-time $19.4 million payment. Neonode received it under its 2019 assignment of patents to Aequitas Technologies, after an Aequitas subsidiary settled its patent case against Samsung. The cash was booked as an investing inflow, not as operating cash, and Neonode paid a $3.9 million broker fee out of operating cash. Leaving out that fee, the 2025 cash shortfall from the business was about $7.2 million (-$0.43 per share). We use the 2023-2025 period as the starting point because it reflects the business after the product-module line was shut down. The median is about -$0.43 per share, or roughly $7 million of cash used each year. The first half of 2026 confirms that rate: $4.0 million was used in operations, revenue was $1.09 million (down 2%), and operating expenses rose 6%. The shortfall grew 21% in 2025. Our median case assumes roughly an $8 million yearly rate from here, which tracks the 2026 actual pace rather than assuming any improvement. Balance sheet. At June 30, 2026 Neonode had $21.3 million of cash and no borrowings apart from a $27,000 finance lease. There are 16.78 million shares. The company has no debt, so the cases below are simply the value of the operations plus the cash. Bear case ($0.13 per share). Spending keeps rising about 6% a year, as it did in the first half of 2026. zForce royalties keep shrinking under maintenance mode, and the car-unit decline already reported continues. MultiSensing stays limited to its current program. The Apple case brings nothing. Cash runs out around the end of 2028, and the company then has to raise money on poor terms or shrink to a small royalty tail. Operations worth about -$19 million, plus $21.3 million of cash and nothing owed, leaves roughly $2.2 million for today's shareholders. Base case ($0.37 per share). Cash use runs at about $8 million a year through 2028, which is the demonstrated 2026 pace. By early 2029, when the money is nearly spent, the company cuts back to a royalty-collection business. Its licensing income is about $2 million a year today; after a lean overhead, that business nets about $0.8 million a year and fades 10% a year as zForce products age out. Neonode has shown it will make cuts like this: it exited product manufacturing in 2024-2025 and stopped selling zForce to new customers in 2025. Operations worth about -$15 million, plus $21.3 million of cash and nothing owed, leaves about $6.2 million. Bull case ($1.32 per share). Two things the business has already started go well. First, the Apple case is decided in Aequitas's favor. This case is in the Northern District of California (21-cv-8872), with mediation due by December 8, 2026 and trial set for February 22, 2027. The key patent, U.S. 8,095,879, has had its challenged claims upheld by the Patent Trial and Appeal Board, and the Federal Circuit affirmed that in July 2024. Samsung settled on the same patent in 2025. We assume Apple settles on terms like Samsung's, which netted Neonode about $15.5 million after the broker fee. Second, MultiSensing license revenue keeps rising with the customer program already in production. License fees rose 15% in the first half of 2026, and MultiSensing license revenue grew more than fivefold in the second quarter. Together these narrow the cash use to about $6 million by 2029 and leave a royalty business netting about $1.5 million a year. Operations worth about -$14 million, plus the settlement (about $14.6 million in today's money), $21.3 million of cash and nothing owed, gives about $22 million. What we included and left out. We gave no credit for MultiSensing winning new customers, for share gains in the growing driver-monitoring market, or for management's goal of rebuilding the business on machine perception. None of these has happened yet, and the company has not shown a repeatable way to turn engineering spending into profit. A positive result in the Apple case is plausible on the patent history, but it has not happened, so it appears only in the bull case. A loss or a small settlement would leave the base case unchanged. Change from our previous estimate. Our August 2026 estimate was $0.45 / $0.65 / $2.25. It assumed Neonode would trim costs toward breakeven over seven to eight years. The 2026 results show costs still rising, with no announced cuts. We now assume the current spending pace continues until the cash is nearly gone, and every case comes down as a result. Accounting judgements. The 2025 broker fee was a one-time cost tied to the Samsung payment, so we excluded it from the normal level of cash use. Payments on office leases are treated as an ongoing cost. The 2023 and 2024 figures include the product-module business that was later shut down. Without it, cash use would have been somewhat lower, but the 2026 actuals show the current cost base is no smaller. What would make this wrong. The main question is whether the cash gets spent before MultiSensing earns its keep. If MultiSensing royalties grow fast enough to cover costs before 2029, or Neonode cuts costs sooner, the value would be closer to the cash on hand. A new share sale at low prices would push the outcome toward the bear case. Separately, the share price has been below $1, and Nasdaq gave notice on August 6, 2026 that the company must meet the $1 minimum bid by February 2, 2027. A reverse stock split is the usual fix, and it would not change the value of the business. Margin-of-safety price ($0.20). The outcomes run from $0.13 to $1.32 per share, and the median value itself shrinks as cash is spent, so a 20% yearly return needs a large discount to the base case. From $0.20, the base case implies roughly 23% a year if the shares reach base value within about three years. The bear case implies a loss of about 35% from that price, while the bull case includes a possible Apple settlement within months.